This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Wednesday, August 13, 2014
Sovaldi Debate Hurts Access for Opioid Treatment Patients
Sovaldi Debate Hurts Access for Opioid Treatment Patients By ED SILVERMAN
The tussle over the cost of the Sovaldi hepatitis C medication may prevent yet another segment of the population from being treated – people who are enrolled in opioid treatment programs.
Although the drug has shown evidence of curing nine of 10 sufferers and theproduct labeling does not suggest Sovaldi is not safe for these patients, payers are balking at covering the medicine for people with a history of a substance use disorder, according to Alcoholism & Drug Abuse Weekly.
No comments:
Post a Comment